Buys
Open market- Shares
- +20,000
- Avg price
- $0.0500
- Total value
- +$1,000
Amit B. Shah - CFO at Oncotelic Therapeutics, Inc.
Issuer-level insider activity
- Role
- Cfo
- Issuer ticker
- OTLC on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Amit B. Shah in Oncotelic Therapeutics, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +20,000
- Share %
- 100%
- Total value
- +$1,000
Reported holdings for Amit B. Shah in Oncotelic Therapeutics, Inc.
Form 4 holding
CFO
Oncotelic Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 378,837
- Estimated value
- $18,941
- Report date
- 22 Jun 2026
- Price
- $0.0500
- Ownership
- Direct
Form 4 holding
CFO
Oncotelic Therapeutics, Inc.
- Security class
- Stock Options
- Shares / value
- 698,256
- Estimated value
- Report date
- 08 Jul 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CFO
Oncotelic Therapeutics, Inc.
- Security class
- Restricted stock Units
- Shares / value
- 1,500
- Estimated value
- Report date
- 10 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Series A Preferred Stock
- Underlying amount
Transaction history for Amit B. Shah in Oncotelic Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.